An Australian tuberous sclerosis cohort: Are surveillance guidelines being met?

Maya Chopra(Boston Children's Hospital), David Mowat(UNSW Sydney), Seán Kennedy(Environmental Protection Agency), John A. Lawson(Universities UK), Christoph K. Camphausen(UNSW Sydney), Peter Taylor(University Hospital of Wales), Deborah Yates(Asbestos Diseases Research Institute), Meredith Wilson(Children's Hospital at Westmead), Gayathri Parasivam(The University of Sydney), Michael F. Buckley(Prince of Wales Hospital), Orli Wargon(UNSW Sydney)
Journal of Paediatrics and Child Health
March 30, 2011
10.1111/j.1440-1754.2011.02038.x
Cited by 23

Related Papers

Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|863
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
|Free Radical Biology and Medicine|2004|697